Počet záznamov: 1
skúšanie klinické, fáza I, ako téma
SYS d017321 LBL 00000cz--a2200000n--4500 005 20250606214106.0 008 920513|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 $d BA006 $d BA006 $d BA006 065 $a E05.318.372.250.250.200 065 $a N05.715.360.330.250.250.200 065 $a N06.850.520.450.250.250.200 066 $a 01 $c 03 089 $a 615.036 150 $a skúšanie klinické, fáza I, ako téma $x CL $x EC $x ES $x HI $x IS $x LJ $x MT $x PX $x SN $x ST $x VE $2 slo 450 $w v $a Clinical Trials, Phase I $2 eng 450 $w v $a Drug Evaluation, FDA Phase I $2 eng 450 $w v $a Evaluation Studies, FDA Phase I $2 eng 450 $w v $a Human Microdosing Trial $2 eng 450 $w v $a Phase 1 Clinical Trial $2 eng 450 $w v $a Phase I Clinical Trial $2 eng 450 $w v $a Phase I Clinical Trials $2 eng 450 $w v $a štúdie klinické, fáza I $2 slo 450 $w v $a štúdie klinické, fáza I, ako téma $2 slo 450 $w v $a pokusy klinické, prvá fáza, ako téma $2 slo 450 $w v $a testy klinické, prvá fáza, ako téma $2 slo 450 $w v $a štúdie vyhodnocovacie, FDA fáza I, ako téma $2 slo 450 $w v $a štúdie vyhodnocovacie, FDA fáza I $2 slo 450 $w v $a štúdie hodnotiace, FDA fáza 1, ako téma $2 slo 450 $w v $a hodnotenie liekov, FDA fáza I, ako téma $2 slo 450 $w v $a štúdia mikrodávková humánna $2 slo 450 $w v $a skúška klinická, fáza 1 $2 slo 550 $7 sllk_us_auth*d033281 $Y Nontherapeutic Human Experimentation $w p $a experimentovanie na ľuďoch, neterapeutické 550 $7 sllk_us_auth*d033281 $Y Nontherapeutic Human Experimentation $w b $a experimentovanie na ľuďoch, neterapeutické 665 $a 2008(1993) $2 eng 665 $a Clinical Trials (1980-1992) $2 eng 665 $a Drug Evaluation (1980-1992) $2 eng 680 9-
$i Works about studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range (if appropriate). These tests also are used to determine pharmacologic and pharmacokinetic properties (toxicity, metabolism, absorption, elimination, and preferred route of administration). They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the U.S. and in other countries. $2 eng 680 $a for general design, methodology, economics, etc. of phase I clinical trials; a different heading CLINICAL TRIAL, PHASE I is used for reports of a specific phase I clinical trial $2 eng 750 -2
$a Clinical Trials, Phase I as Topic $2 eng 980 $x M
Počet záznamov: 1